# ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease

> **NCT03499964** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Urotronic Inc.** · enrollment: 127 (actual)

## Conditions studied

- Urethral Stricture

## Interventions

- **DEVICE:** Optilume Drug Coated Balloon (DCB)
- **DEVICE:** Control Treatment

## Key facts

- **NCT ID:** NCT03499964
- **Lead sponsor:** Urotronic Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2018-06-22
- **Primary completion:** 2020-12-10
- **Final completion:** 2026-03
- **Target enrollment:** 127 (ACTUAL)
- **Last updated:** 2025-10-15

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03499964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03499964, "ROBUST III- Re-Establishing Flow Via Drug Coated Balloon For The Treatment Of Urethral Stricture Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03499964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*